The Study of Efficacy and Safety of Mexidol® in Stroke Therapy (MIR)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The main purpose of the clinical trial is to assess efficacy and safety of Mexidol® in sequential treatment (solution for intravenous and intramuscular administration 50 mg/ml + film-coated tablets 250 mg) of patients in the acute and early recovery periods of ischemic stroke.
Epistemonikos ID: 8e89d4d3fba781ade8b7b4fdfa6b9ab4bab5ec33
First added on: Jun 01, 2024